Literature DB >> 17241669

Problems with spontaneously hypertensive rats (SHR) as a model of attention-deficit/hyperactivity disorder (AD/HD).

Brent Alsop1.   

Abstract

Spontaneously hypertensive rats (SHR) have been promoted as animal models of attention-deficit hyperactivity disorder (AD/HD). Free-operant experiments have compared the effects of simple schedules, extinction, delayed reinforcers, and non-contingent reinforcement on the behaviour of SHR and Wistar Kyoto (WKY) controls. Differences between SHR and WKY performance have been paralleled with the overactivity, impulsiveness, and inattention that characterize AD/HD. Re-examination of selected studies suggests that differences in these strains' overall response rates can exaggerate other differences between SHR and WKY performance. Removing this confounding factor can reduce differences between these two strains' behaviours.

Entities:  

Mesh:

Year:  2006        PMID: 17241669     DOI: 10.1016/j.jneumeth.2006.12.002

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  21 in total

1.  Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder.

Authors:  Julie A Marusich; William Travis McCuddy; Joshua S Beckmann; Cassandra D Gipson; Michael T Bardo
Journal:  Behav Pharmacol       Date:  2011-12       Impact factor: 2.293

2.  Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD.

Authors:  Mattis B Wigestrand; Yann S Mineur; Christopher J Heath; Frode Fonnum; Marina R Picciotto; Sven Ivar Walaas
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

3.  Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats.

Authors:  Thomas E Wooters; Michael T Bardo
Journal:  Brain Res       Date:  2011-05-01       Impact factor: 3.252

Review 4.  Animal models to guide clinical drug development in ADHD: lost in translation?

Authors:  Jeffery R Wickens; Brian I Hyland; Gail Tripp
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 5.  Sex, ADHD symptoms, and smoking outcomes: an integrative model.

Authors:  Elizabeth E Van Voorhees; John T Mitchell; F Joseph McClernon; Jean C Beckham; Scott H Kollins
Journal:  Med Hypotheses       Date:  2012-02-15       Impact factor: 1.538

6.  Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.

Authors:  Sucharita S Somkuwar; Mahesh Darna; Kathleen M Kantak; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2013-04-23       Impact factor: 5.858

Review 7.  The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain.

Authors:  Terje Sagvolden; Espen Borgå Johansen; Grete Wøien; S Ivar Walaas; Jon Storm-Mathisen; Linda Hildegard Bergersen; Oivind Hvalby; Vidar Jensen; Heidi Aase; Vivienne A Russell; Peter R Killeen; Tania Dasbanerjee; Frank A Middleton; Stephen V Faraone
Journal:  Neuropharmacology       Date:  2009-08-19       Impact factor: 5.250

8.  The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Vivienne A Russell; Greg A Gerhardt; Paul E A Glaser
Journal:  Neuropharmacology       Date:  2012-09-01       Impact factor: 5.250

9.  Nicotine-induced behavioral sensitization in an adult rat model of attention deficit/hyperactivity disorder (ADHD).

Authors:  Elizabeth Watterson; Alexander Spitzer; Lucas R Watterson; Ryan J Brackney; Arturo R Zavala; M Foster Olive; Federico Sanabria
Journal:  Behav Brain Res       Date:  2016-06-27       Impact factor: 3.332

Review 10.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.